Real world outcomes comparing the use of GLP-1 agonists in patients with renal cell carcinoma (RCC) and comorbid obesity: A propensity score matched analysis from Global Federated Health Research Network.

Yajur Arya(Thomas Jefferson University Hospital), Nitya Batra(Jacksonville College), Arshi Syal(Thomas Jefferson University Hospital), Oluwatayo Adeoye(Jacksonville College), Himil Mahadevia(Jacksonville College)
Journal of Clinical Oncology
March 1, 2026
Cited by 0


Related Papers